Showing results (71-80 of 343) with videos related to
Sort By:
Pageof 35
Liver International : Official Journal of the International Association for the Study of the Liver|March 12, 2025
Risk of Serious Bacterial and Non-Bacterial Infections in People With MASLDGiovanni Targher, Herbert Tilg, Luca ValentiExpert Opinion on Biological Therapy|August 2, 2007
Mode of function of biological anti-TNF agents in the treatment of inflammatory bowel diseasesHerbert Tilg, Alexander Moschen, Arthur KaserGut|August 18, 2016
Antibiotics as deep modulators of gut microbiota: between good and evilGianluca Ianiro, Herbert Tilg, Antonio GasbarriniCardiovascular Research|June 26, 2023
Non-alcoholic fatty liver disease: pathophysiological concepts and treatment optionsChristoph Grander, Felix Grabherr, Herbert TilgClinical and Translational Gastroenterology|January 13, 2021
Increased Fecal Neopterin Parallels Gastrointestinal Symptoms in COVID-19Felix Grabherr, Maria Effenberger, Alisa Pedrini, et al.Nature Reviews. Gastroenterology & Hepatology|October 13, 2016
NAFLD and diabetes mellitusHerbert Tilg, Alexander R Moschen, Michael RodenEuropean Cytokine Network|March 26, 2009
Suppression of interleukin-17 by type I interferons: a contributing factor in virus-induced immunosuppression?Herbert Tilg, Alexander R Moschen, Arthur KaserGut Microbes|October 10, 2023
Microbial-host-isozyme: unveiling a new era in microbiome-host interactionLei Miao, Herbert Tilg, Ming-Hua ZhengGut and Liver|November 22, 2012
Dietary Factors: Major Regulators of the Gut's MicrobiotaAlexander R Moschen, Verena Wieser, Herbert TilgHepatology (Baltimore, Md.)|January 17, 2016
Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitisHerbert Tilg, Alexander R Moschen, Gyongyi SzaboPageof 35